WebDailyMed - ONDANSETRON tablet, film coated Label: ONDANSETRON tablet, film coated NDC Code (s): 61919-087-10, 61919-087-15 Packager: Direct_Rx This is a repackaged label. Source NDC Code (s): 65862-188 Category: HUMAN PRESCRIPTION DRUG LABEL DEA Schedule: None Marketing Status: Abbreviated New Drug Application Drug Label … WebNov 28, 2024 · 2 mg/kg orally daily for 8 to 12 weeks (maximum cumulative dose 168 mg/kg); treatment beyond 90 days increases the probability of sterility in males …
Aprepitant - Wikipedia
WebThe National Library of Medicine (NLM), on the NIH campus in Bethesda, Maryland, is the world's largest biomedical library and the developer of electronic information services that delivers data to millions of scientists, health professionals and members of the public around the globe, every day. con of states
Cyclophosphamide - National Library of Medicine Search …
WebModerate-dose therapy: 10-15 mg/kg weekly as a single dose. High-dose therapy: 20-40 mg/kg as a single dose every 10-20 days. Alternative dosing regimens: For daily therapy: 3-6 mg/kg (approx 120-240 mg/m 2 ). For intermittent therapy: 10-15 mg/kg (approx 400-600 mg 2) at intervals of 2-5 days. WebThiotepa (INN), sold under the brand name Tepadina, is a medication used to treat cancer.. Thiotepa is an organophosphorus compound with the formula (C 2 H 4 N) 3 PS. It is an analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate.It is manufactured by heating aziridine with … WebOndansetron orally disintegrating tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2. nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. editing abc files